Monday, June 4, 2007

 Paxil

 Paxil pregnancy warning strengthened again.(News) Clinical Psychiatry News - Find Articles

 FIND  IN free and premium articles free articles only premium articles only this publication Arts & Entertainment Automotive Business & Finance Computers & Technology Health & Fitness Home & Garden News & Society Reference & Education SportsAdvancedSearch  (Related) 

saveprint  (Related) share  (Related) link

 Paxil pregnancy warning strengthened again.(News)
 Content provided

 in partnership with

  The Food and Drug Administration has stepped up warnings that paroxetine increases the risk of congenital defects, especially cardiovascular malformations.

  In September, GlaxoSmithKline, which markets paroxetine under the trade name Paxil, had updated the drug's labeling in conjunction with the FDA. The change was based on initial data from a U.S. insurance claims database indicating a slightly higher risk of fetal defects in women who had taken the drug in the first trimester.

  When further information became available in December, GlaxoSmithKline and the FDA agreed that ...



















No comments: